Company Analysis
Sign in

Inovio Pharmaceuticals, Inc. (INO)

Nasdaq: INO · Pharmaceutical Preparations · Plymouth Meeting, PA · filing with the SEC since 1999
Full chart Alerts Compare
Grade3.5
◀ Past 3.2● Present 3.3▶ Future 3.9
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

91 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Inovio Pharmaceuticals, Inc.’s names, not what it holds today.

Patents granted
91
89 utility, 2 design, 1976 to Dec 31, 2025
Granted in 2025
8
Against 15 in 2024 and 12 in 2023
Applications published
144
9 of them in 2025
Names they are printed under
3
its own name, a former name
By yearGrantedApplications published
'09'11'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals42
Medical technology13
Biotechnology4
Electrical machinery, apparatus, energy1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name3 counted
Inovio Pharmaceuticals, Inc. its own name
named as the applicant on its applications, in US
0 granted
138 published
Inovio Pharmaceuticals, Inc. its own name
US, as the owner printed on each patent
89 granted
6 published
Genetronics Biomedical Corporation a former name
US, as the owner printed on each patent
2 granted
0 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 9, 202512,492,243DNA antibody constructs for use against Pseudomonas aeruginosaPharmaceuticalsInovio Pharmaceuticals, Inc.
Dec 9, 202512,491,361Tolerable and minimally invasive skin electroporation devicePharmaceuticalsInovio Pharmaceuticals, Inc.
Nov 25, 202512,478,667Vaccines for recurrent respiratory papillomatosis and methods of using the samePharmaceuticalsInovio Pharmaceuticals, Inc.
Jul 8, 202512,350,318Combination therapy to treat brain cancerPharmaceuticalsInovio Pharmaceuticals, Inc.
Apr 29, 202512,285,473Cancer vaccines targeting MUC16 and uses thereofPharmaceuticalsInovio Pharmaceuticals, Inc.
Apr 22, 202512,280,108Vaccines having an antigen and interleukin-21 as an adjuvantPharmaceuticalsInovio Pharmaceuticals, Inc.
Mar 18, 202512,251,561Minimally invasive dermal electroporation deviceMedical technologyInovio Pharmaceuticals, Inc.
Mar 4, 202512,240,872Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using samePharmaceuticalsInovio Pharmaceuticals, Inc.
Dec 10, 202412,161,706Cancer vaccines targeting BORIS and uses thereofPharmaceuticalsInovio Pharmaceuticals, Inc.
Oct 29, 202412,128,229Oral mucosal electroporation device and use thereofMedical technologyInovio Pharmaceuticals, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Nov 20, 20252025/0352620COMBINATION THERAPY TO TREAT BRAIN CANCERPharmaceuticalsInovio Pharmaceuticals, Inc.
Oct 16, 20252025/0319178Cancer Vaccines and Methods of Treatment Using The SamePharmaceuticalsInovio Pharmaceuticals, Inc.
Aug 14, 20252025/0257101Filovirus Consensus Antigens, Nucleic Acid Constructs and Vaccines Made Therefrom, and Methods of Using SamePharmaceuticalsInovio Pharmaceuticals, Inc.
Aug 14, 20252025/0255957VACCINES HAVING AN ANTIGEN AND INTERLEUKIN-21 AS AN ADJUVANTPharmaceuticalsInovio Pharmaceuticals, Inc.
Jul 10, 20252025/0222086CANCER VACCINES TARGETING MUC16 AND USES THEREOFPharmaceuticalsInovio Pharmaceuticals, Inc.
Apr 17, 20252025/0121054VACCINES AGAINST CORONAVIRUS AND METHODS OF USEPharmaceuticalsInovio Pharmaceuticals, Inc.
Mar 27, 20252025/0101399Consensus Prostate Antigens, Nucleic Acid Molecule Encoding The Same And Vaccine And Uses Comprising The SamePharmaceuticalsInovio Pharmaceuticals, Inc.
Feb 20, 20252025/0057929CANCER VACCINES TARGETING BORIS AND USES THEREOFPharmaceuticalsInovio Pharmaceuticals, Inc.
Jan 9, 20252025/0011401OPTIMIZED NUCLEIC ACID ANTIBODY CONSTRUCTSPharmaceuticalsInovio Pharmaceuticals, Inc.
Dec 5, 20242024/0399129KINETIC VACUUM TREATMENT DEVICES, SYSTEMS, AND METHODSMedical technologyInovio Pharmaceuticals, Inc.
What it applied for, 2024 to 2025: Pharmaceuticals 26 · Medical technology 4 · Biotechnology 2 · Electrical machinery, apparatus, energy 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton INO · research, not advice